The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease. “After learning about the use of edaravone to treat ALS in Japan, we rapidly engaged with the drug developer about filing a marketing application in the United States,” said Eric...
Post
Charlie Sheen ‘suffered borderline dementia from his old HIV drugs’ – that he says was cured by new drug in a clinical trial
Sheen, 51, revealed his HIV-positive diagnosis in November 2015 In early 2016, he joined a Phase III clinical trial for PRO-140, an intravenous injection that is done once a week, rather than taking daily pills Last year Sheen told Daily Mail Online he experienced a ‘transformation’ after switching from the ‘cocktail of drugs’ to PRO-140...
Post
Traumatic brain injuries may be helped with drug used to treat bipolar disorder
A drug used to treat bipolar disorder and other forms of depression may help to preserve brain function and prevent nerve cells from dying in people with a traumatic brain injury, according to a new Rutgers University study. In research published in Scientific Reports, Rutgers scientists discovered that lithium – used as a mood stabilizer and...
Post
Type 1 diabetes cured in mice using gene therapy
Researchers from the University of Texas Health Science Center in San Antonio have found a way to cure type 1 diabetes in mice. It is hoped that the novel technique – which boosts insulin secretion in the pancreas – will reach human clinical trials in the next 3 years. Researchers have successfully used gene therapy...
Post
Could a CURE for eczema be in sight? Experts finally discover what is triggering the skin condition after years of research
For years, scientists have been unsure as to what triggers the skin condition Those affected have been given creams aimed at relieving their symptoms But new research offers hope of an eventual treatment targeting the root cause They discovered sufferers are missing a vital protein called filaggrin in their skin A cure for eczema could...
Post
Many US-approved drugs pack serious side effects later, study shows
CHICAGO (AP) — Almost one-third of new drugs approved by U.S. regulators over a decade ended up years later with warnings about unexpected, sometimes life-threatening side effects or complications, a new analysis found. The results covered all 222 prescription drugs approved by the U.S. Food and Drug Administration from 2001 through 2010. The researchers looked...
Post
Are skin conditions linked to type 2 diabetes?
Skin complications usually occur when blood sugar levels are too high, and they are often the first visible sign of diabetes. An estimated one-third of people with diabetes experience skin conditions either related to or influenced by the condition. Medication options exist, but managing blood sugars is normally the best prevention and treatment option. Type 2 diabetes and skin...
Post
Scrib protein identified as a natural suppressor of liver cancer
Dr. Satya Ande (left) and Research Assistant Jinling Yuan. A protein that typically helps keep cells organized and on task becomes a tumor suppressor in the face of liver cancer, scientists say. The protein Scrib, which is emerging as both a tumor suppressor and oncogene depending on the cancer type, appears in liver cancer to migrate out of...
Post
New nanotechnology application for difficult-to-treat cancers
A new treatment combining shock waves with nanoparticles can successfully treat tumours that are difficult to target using conventional chemotherapy. This is the first time this combined therapy has been tested in live animals. The findings of this pre-clinical study, published in the journal Endocrine-Related Cancer, could lead to the development of more effective therapies for...
Post
Brain cancer study reveals therapy clues
Researchers have pinpointed two key molecules that drive the growth of an aggressive type of adult brain cancer. The findings shed light on the mechanisms that underpin brain cancer progression and could eventually reveal targets for the development of much-needed therapies, researchers say. Lab tests Scientists conducted lab tests on tumour cells from patients with glioblastoma, a rare but...